Skip to content
Home
Visit our other Journals
About
Supporter
Expert Index
Editorial Board
Editorial Team
Editorial Policy
Contact
Sign up
Visit
Diseases
Alzheimer's Disease
Dementia
Dementia with Lewy Bodies
Frontotemporal Dementia
Vascular Dementia
Mild Cognitive Impairment
View all Diseases
Topics
Diagnostics
Biology
Biomarkers
Treatment
Clinical Care
Prevention
View all Topics
Conferences
AAIC 2023
BNA 2023
AD/PD 2023
ARUK 2023
CTAD 2022
AAIC 2022
View all Conferences
Features
Podcasts
About
Supporter
Expert Index
Editorial Board
Editorial Team
Editorial Policy
Contact
Sign up
Alzheimer’s Disease
1:38
ALZ-NET: examining novel approved treatments in the real-world
Rebecca Edelmayer
• 18 May 2023
1:26
Topline donanemab results: most positive Phase III data to date
Rebecca Edelmayer
• 18 May 2023
2:23
Overcoming the limitations of iPSC models
Julia TCW
• 24 Apr 2023
2:25
Impact of APOE4 on cellular function in astrocytes and microglia
Julia TCW
• 24 Apr 2023
1:12
Alzheimer’s disease functional genomics with iPSCs
Julia TCW
• 24 Apr 2023
2:04
Unveiling the role of astrocytes in Alzheimer’s disease for novel therapeutic strategies
Julia TCW
• 24 Apr 2023
5:33
Unravelling sex and gender differences in brain and mental diseases
Antonella Chadha Santuccione
• 18 Apr 2023
1:55
Next-generation anti-amyloid therapies: prioritizing selectivity
Mourad Tayebi
• 30 Mar 2023
2:04
Anti-amyloid combination strategies in Alzheimer’s disease
David Greeley
• 28 Mar 2023
3:38
Sex differences in Alzheimer’s disease: women’s journey, challenges, and implications
Antonella Chadha Santuccione
• 18 Apr 2023
2:39
Detecting retinal Aβ: a promising path for non-invasive Alzheimer’s disease diagnosis
Mourad Tayebi
• 30 Mar 2023
6:04
Development of Appropriate Use Recommendations for lecanemab
Stephen Salloway
• 19 Apr 2023
5:01
The potential of calcineurin inhibitors in reducing the prevalence of dementia.
Jacqueline Silva
• 17 Apr 2023
2:36
Prospects for Alzheimer’s disease monitoring and treatment in 2023
Stephen Salloway
• 19 Apr 2023
1:51
Why target vascular dysfunction in Alzheimer’s disease?
Silvia Anderle
• 24 Apr 2023
1:36
Unleashing the potential of microglia as a therapeutic target
Emma Mead
• 24 Apr 2023
Previous
1
2
3
4
5
6
7
8
9
…
57
Next